ADARx Pharmaceuticals, Inc. (ADRX) Ownership
ADRX ownership summary
as of October 17, 2026- Institutions
- 32.7% of shares outstanding
- Insiders
- 41.78% of shares outstanding
- Shares outstanding
- 106.8M
- Float
- 49.4M shares available to trade
- Short interest
- — 1.2M shares short
- Days to cover
- 0.62
- Institutions 32.73%
- Insiders 41.78%
- Other investors 25.49%
ADRX top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Pacific Select Health Sciences I | 0.04% | 44K | $775,153 | +43,918 (0.0%) | September 30, 2026 |
| 2 | T. Rowe Price Health Care ETF | <0.01% | 2,128 | $37,559 | — | September 30, 2026 |
| 3 | T. Rowe Price Biotech ETF | <0.01% | 952 | $16,803 | — | September 30, 2026 |
| 4 | T. Rowe Price Small-Cap ETF | <0.01% | 426 | $7,519 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
Who owns ADRX
Institutional investors own 32.7% of ADARx Pharmaceuticals's shares and insiders 41.78%.
Related: ADRX key metrics. See the ADRX stock overview for the latest quote and news.
ADRX ownership FAQ
What percentage of ADARx Pharmaceuticals is owned by institutions?
Institutions hold 32.7% of ADARx Pharmaceuticals's shares outstanding; insiders hold 41.78%.
Which funds own ADARx Pharmaceuticals?
The largest fund holders of ADARx Pharmaceuticals are Pacific Select Health Sciences I (0.04%), T. Rowe Price Health Care ETF (<0.01%), T. Rowe Price Biotech ETF (<0.01%), T. Rowe Price Small-Cap ETF (<0.01%).
How many shares of ADARx Pharmaceuticals are outstanding?
ADARx Pharmaceuticals has 106.8M shares outstanding, of which 49.4M are in the public float.